Zocor Lawsuits | Zocor Side Effects Risk

Zocor Side Effects: How High Is the Risk for Diabetes?

Whitney Taylor | February 22nd, 2012

Plaintiffs who have filed lawsuits because of Zocor side effects typically complain of muscle injury and liver damage. However, recent studies showing a link between the cholesterol-lowering statin and a high diabetes risk may influence future lawsuits. According to reports, post-menopausal women could be the highest risk group for Zocor diabetes.

New studies could provoke Zocor claims

Last year, the Journal of the American Medical Association (JAMA) published an analysis of five different studies that showed a link between use of statins like Zocor and a higher incidence of diabetes. This analysis showed that those taking higher doses of Zocor were more likely to develop diabetes than those taking moderate dosages of the drug.

This increased risk appears to mirror that of other Zocor side effects like muscle injury, which have been more prevalent in individuals taking the highest 80 mg dose of Zocor daily. Patients who have suffered muscle injury and kidney failure after taking the 80mg regimen of Zocor may be eligible to win compensation for their injuries by filing Zocor lawsuits.

“Overall, we found that high doses were associated with a 12-percent increased risk of diabetes, compared with standard doses,” Dr. Kausik Ray, a co-author of one of the studies, was reported saying at CBS News.

Most of the researchers agree that for most patients the benefits of statins outweigh the risk of Zocor diabetes.

New study finds greater risk of Zocor side effects in older women

A more recent study published in the Archives of Internal Medicine last month suggests that the risk of Zocor side effects like diabetes might actually be greater – at least for women in the post-menopausal years.

This study, conducted by a number of researchers from various medical institutions, found that women in this age group were 48 percent more likely to develop Zocor diabetes than those who did not take the statin. The study, which was reported in the Los Angeles Times, indicated that the highest risk was found in Asian women and those with healthy body mass indexes, or BMIs.

The researchers recommend that further studies on Zocor side effects be conducted to determine the reason for the differing risk. They also state that diet and exercise should be the first course of action in patients who are still healthy, but have some risks for heart disease, like elevated cholesterol.

Whether this new research will fuel the fire for additional Zocor lawsuits remains to be seen. For now, it is important for patients and doctors to carefully weigh the risk of Zocor diabetes when determining the best course of treatment for women with elevated cholesterol levels.